Sanofi (NASDAQ:SNY) Position Lifted by Capital Investment Counsel LLC

Capital Investment Counsel LLC grew its stake in shares of Sanofi (NASDAQ:SNY) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,958 shares of the company’s stock after acquiring an additional 1,471 shares during the period. Capital Investment Counsel LLC’s holdings in Sanofi were worth $3,278,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of SNY. Stablepoint Partners LLC lifted its stake in Sanofi by 0.8% during the third quarter. Stablepoint Partners LLC now owns 23,893 shares of the company’s stock worth $1,377,000 after purchasing an additional 189 shares during the last quarter. PDS Planning Inc raised its holdings in shares of Sanofi by 3.1% during the third quarter. PDS Planning Inc now owns 6,643 shares of the company’s stock worth $383,000 after purchasing an additional 200 shares during the period. Eagle Ridge Investment Management lifted its position in shares of Sanofi by 3.8% in the 3rd quarter. Eagle Ridge Investment Management now owns 5,571 shares of the company’s stock worth $321,000 after buying an additional 203 shares during the last quarter. Financial Advocates Investment Management boosted its holdings in shares of Sanofi by 3.4% in the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock valued at $365,000 after buying an additional 206 shares during the period. Finally, Angeles Investment Advisors LLC grew its position in shares of Sanofi by 1.9% during the 3rd quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock valued at $653,000 after buying an additional 210 shares during the last quarter. Institutional investors own 14.04% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Stock Down 0.7 %

SNY stock opened at $52.97 on Wednesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65. The firm has a market cap of $134.43 billion, a PE ratio of 27.03, a P/E/G ratio of 1.19 and a beta of 0.57. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97. The firm has a 50 day simple moving average of $48.90 and a 200 day simple moving average of $52.22.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.